- About About
-
Medical
Medical
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
-
Advocacy
Advocacy
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
-
Policy
Policy
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
-
-
Online Resource on Medical Cannabis Available
“Whether or not doctors or other health care professionals have any intention of recommending medical cannabis for patient care, they all need to be well educated in this clinical area because their patients will be seeking their expert advice and guidance for this medication,” noted Stephen B. Corn, MD, a specialist in anesthesiology, perioperative and pain medicine at Brigham and Women’s Hospital and Children’s Hospital, both in Boston. Since patients may already be using medical marijuana, clinicians “need to be aware of the physiological effects of cannabis as well as potential drug interactions and side effects,” Dr. Corn added, stressing that expertise in medical cannabis will be necessary for most doctors, pharmacists, nurses and other health care professionals.
Clinicians who care for patients using cannabis for medical purposes legally now have an online resource, the Cannabis Care Certification (CCC) program, which is designed to provide information about medical cannabis to individuals who are starting or considering cannabis therapy and health care professionals looking to learn about the endocannabinoid system and medical cannabis.
The CCC’s Patient & Caregiver Education Program features two hours of video education addressing dosage, titration, labeling of cannabis therapeutics, transporting medical cannabis and more. People who sign up for the Patient & Caregiver Program also receive a free legal overview and a list of requirements for participating in their state Medical Cannabis Program, and those who complete the program receive a Cannabis Care Patient and Caregiver Certification.
CCC’s Medical Professional Education Program covers the endocannabinoid system as well as the therapeutic use of cannabis for several disease states. The content and its presentation are designed to be of educational value to people who are new to medical cannabis therapy as well as those with years of experience in this area of clinical practice.
Successful completion of the Medical Professional Program culminates in the health care professional being awarded a certification, continuing medical education (CME) credits, a patient education subscription and an option to be listed in the referral section of the CCC website.
“Whether or not doctors or other health care professionals have any intention of recommending medical cannabis for patient care, they all need to be well educated in this clinical area because their patients will be seeking their expert advice and guidance for this medication,” noted Stephen B. Corn, MD, a specialist in anesthesiology, perioperative and pain medicine at Brigham and Women’s Hospital and Children’s Hospital, both in Boston. Since patients may already be using medical marijuana, clinicians “need to be aware of the physiological effects of cannabis as well as potential drug interactions and side effects,” Dr. Corn added, stressing that expertise in medical cannabis will be necessary for most doctors, pharmacists, nurses and other health care professionals.
The CCC program was launched in December by Americans for Safe Access and The Answer Page, a website that provides peer-reviewed CME content focused on the endocannabinoid system and the therapeutic use of medical cannabis, pain medicine and opioid prescribing. For more information, visit www.theanswerpage.com and www.CannabisCareCertification.org.
Share